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The protein encoded by HSRG1 (HSV-1 stimulation-related gene 1) is a virally induced protein expressed in HSV-1-infected 
cells. We have already reported that HSRG1 is capable of interacting with transcriptional regulator proteins. To further analyze 
the effects of HSRG1 on the regulation of viral gene transcription, we expressed the HSRG1 protein in transfected cells and 
found that it postpones the proliferation of HSV-1. CAT (chloramphenicol acetyltransferase) assays also revealed that HSRG1 
reduces transcription from HSV-1 promoters. Yeast two-hybrid and immunoprecipitation assays indicated that HSRG1 inter-
acts with Cyclin T2, the regulatory subunit of P-TEFb, which is required for transcription elongation by RNA Pol II (RNAP II), 
and that amino acid residues 1-420 in Cyclin T2 are important for binding with HSRG1. Fluorescence assays suggested that 
the cellular localizations of those two proteins are influenced by their interaction. Further analyses with CAT assays revealed 
that HSRG1 inhibits the transcriptional activation by Cyclin T2 of viral promoters. Our results suggested that the inhibitory ef-
fects of HSRG1 on viral replication and proliferation are probably induced by its binding to Cyclin T2. Therefore, it is likely 
that HSRG1 inhibits viral gene transcriptional elongation by interacting with Cyclin T2. 
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Herpes simplex virus 1 (HSV-1), a DNA virus possessing 
both complicated transcriptional mechanisms and genome 
structure [1], can interact with a latently or lytically infected 
host [2,3]. Viral components interact with host structural 
proteins, as well as particular cellular proteins expressed 
during HSV-1 infection. These interactions can affect the 
function of cellular components, thereby altering biological 
processes [4,5]. Existing data demonstrate that cellular ex-
pression profiles change in HSV-1-infected cells and have 
different effects on viral proliferation [6]. Our earlier work 
focused on analyzing changes in gene expression induced 
by HSV-1 infection in human fibroblasts; HSRG1, encoded 
by the HSV-1 stimulation-related gene, is one of these pro-
teins [7]. HSRG1 is expressed 2 h after infection and is 
classified as a SAND protein family member [8], containing 
a eukaryotic conserved domain [9] of unknown biological 
function. Our earlier work also indicated that HSRG1 inter-
acts with the SV40 large T-antigen (LT), altering transcrip-
tional regulation of LT from the SV40 promoter [10]. These 
results suggested that HSRG1 could interact with transcrip-
tional regulatory proteins. In the present study, we screened 
candidate cellular proteins that could interact with HSRG1 
by a yeast two-hybrid assay, and our results showed that 
Cyclin T2 was one such protein. Cyclin T2 is an important 
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transcriptional regulator. Previous studies have shown that 
Cyclin T2 binds with CDK9 to form the P-TEFb complex 
(positive transcription elongation factor b, P-TEFb), which 
regulates transcriptional elongation of RNA polymerase II 
(RNAP II) by phosphorylating transcription-related fac-
tors [11]. RNAP II has an important and non-specific role 
in the gene transcription processes [12], and the interaction 
of HSRG1 with the Cyclin T2 subunit of the P-TEFb com-
plex indicates that the cellular and viral gene transcriptional 
process might be affected by this interaction during HSV-1 
infection. In the present study, we investigated the possible 
mechanisms and biological significance of HSRG1 in 
HSV-1 infection. 
1  Materials and methods 
1.1  Cells and viruses 
China hamster ovarian cancer cells (CHO-K1) and African 
green monkey kidney cells (Vero) from our laboratory were 
grown in F12 supplemented with 10% (v/v) of fetal bovine 
serum in T-75 cell culture containers or six-well plates. 
HSV-1 (F strain) was also provided from our laboratory. 
1.2  Plasmid construction 
Recombination plasmid pcDNA3-CycT2a was constructed 
by ligating the Cyclin T2 gene into the eukaryotic expres-
sion plasmid, pcDNA3.1 (Invitrogen). The gene encoding 
Cyclin T2 was obtained by PCR amplification with primers 
CycT2a-F1 and CycT2a-R1 (Table 1). Eukaryotic expres-
sion plasmid pcDNA3-HSRG1, expressing HSRG1, has 
already been constructed in our laboratory [10]. Recombi-
nation plasmid pGADT7-HSRG1 was constructed by ligat-
ing the HSRG1 gene (amplified with primers HSRG1-F1 
and HSRG1-R1) into the pGADT7 vector (Clontech). Fur-
thermore, pGBKT7-CycT2a, pGBKT7-T2a-250A, pGBKT7- 
T2a-300A, and pGBKT7-T2a-420A were constructed sepa-
rately by inserting the sequence of Cyclin T2 cDNA, or 
sequences encoding Cyclin T2 amino acids 1−250, 1−300, 
or 1–420, into the pGBKT7 vector (Clontech). The Cyclin 
T2 cDNA and deletion fragments were amplified with 
primers CycT2-F, CycT2-R; CycT2-F, CycT2-250A-R; 
CycT2-F, CycT2-300A-R; CycT2-F; and CycT2-420A-R, 
respectively (Table 1). In addition, pRed-HSRG1 was con-
structed by inserting the HSRG1 gene (primers CycT2-F2 
and CycT2-R2) into the pDsRed-N1 vector (Clontech). Pro-
karyotic expression plasmid pGEX-4T-CycT2a expressing 
the Cyclin T2a cDNA was donated by Professor Matija Pe-
terlin. Plasmids pCAT-α4, pCAT-TK, and pCAT-gC plas-
mids were constructed in this laboratory [13]. All recombi-
nant plasmids were confirmed by enzymatic digestion and 
DNA sequencing. 
Table 1  Primers for PCR amplification 












1.3  Plaque assay 
Vero cells were transfected with pcDNA3-HSRG1 or 
pcDNA3, incubated for 24 h at 37°C, and then infected with 
HSV-1 at MOI 0.5 (multiplicity of infection (MOI)=ratio of 
infectious virus particles to cells) for absorption for 30 min at 
37°C. Viruses were harvested at 24 h and the virus titer was 
tested by a virus plaque assay and counting plaque forming 
units (PFU) mL−1 of samples. The results were presented as 
mean values obtained from three independent experiments. 
1.4  Yeast two-hybrid assay  
Y187 yeast cells transformed with the recombinant plasmid 
pGADT7-HSRG1 were fused with AH109 yeast cells 
transformed with recombinant plasmid pGBKT7-CycT2a or 
pGBKT7-T2a-250A/300A/420A in accord with standard 
protocols (http://www.clontech.com/products/detail.asp?  
product_id=206489&tabno=6). The resulting clones were 
inoculated into two volumes of YPDA medium for incuba-
tion for 20–24 h at 30°C. The fused culture was inoculated 
onto SD/-Leu-Trp plates for incubation for one week at 
30°C. Colonies were inoculated onto SD/-His-Leu-Trp and 
SD/-Ade-His-Leu-Trp plates and incubated for one week at 
30°C, and positive clones were screened. 
1.5  β-galactosidase (β-gal) activity detection 
Clones were picked and inoculated into 5 mL SD/-Leu-Trp 
liquid medium with shaking (200 r min−1) overnight at 30°C 
and then trans-inoculated into YPDA medium with contin-
ued shaking for 3–5 h at 30°C. A600 values were recorded. 
Yeast cells were collected when the A600 value reached 
0.5–0.8. Samples were mixed with 4 mg mL−1 or-
tho-Nitrophenyl-β-galactoside (ONPG) and incubated at 
30°C until the solution turned a yellow color. The reaction 
time was recorded. The values for 420 nm light absorption 
were recorded using a spectrophotometer after removing 
cell debris. β-D-galactosidase content was calculated by the 
following formula: β-D-galactosidase units=1000×A420/t× 
5×A600 (where A600 is equal to the A600 absorption value of 1 
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mL culture and t is the reaction time). The experiment was 
repeated three times with positive (pGBK-p53+pACT-LT) 
and negative (pGBK-Lam+pACT-LT) controls. 
1.6  Cell transfection 
CHO cells, grown in six-well plates to 90% confluence, were  
transfected using Lipofectamine 2000 (Invitrogen) and the  
appropriate plasmid, according to the manufacturer’s in- 
structions (http://tools.invitrogen.com/content/sfs/manuals/  
lf2k_reverse_transfection_web.pdf). 
1.7  Preparation of Cyclin T2 antibodies 
The E. coli BL21 bacterial strain was transfected with the 
pGEX-4T-CycT2a plasmid expressing the GST-CycT2a 
fusion protein following IPTG induction. The purified pro-
tein was obtained by excising an SDS-PAGE gel band that 
contained a protein with the corresponding molecular 
weight and electroeluting the protein. The same volumes of 
the purified GST-CycT2a fusion protein and complete 
Freund’s adjuvant were emulsified and mixed for multiple 
abdominal subcutaneous injections into Kunming mice. The 
mice were boosted with incomplete Freund’s adjuvant 
emulsions at week 2 and 4. Blood was taken from the eye-
ball two weeks after the 3rd immunization for preparation 
of Cyclin T2 antiserum. 
1.8  Immunoprecipitation and Western blotting  
Vero cells incubated for 36 h after co-transfection with 
pcDNA3-HSRG1 and pcDNA3-CycT2a plasmids were 
rinsed with PBS three times, scraped, treated with RIPA 
lytic solution (150 mmol L−1 NaCl, 1% NP-40, 0.5% so-
dium deoxycholate, 0.1% SDS, 50 mmol L−1 Tris·HCl, pH 
7.5) and incubated in an ice bath for 30 min. Protein super-
natants were collected by centrifugation. An aliquot of the 
supernatant was reserved as an input sample. Immunopre-
cipitation of HSRG1 and Cyclin T2 was carried out accord-
ing to standard procedures. Antibodies against HSRG1 were 
added to the remaining lysate supernatants and incubated 
for 2 h at 37°C. Immune complexes were precipitated by 
incubation with Protein A agarose (Beyotiome). Following 
incubation, tubes were centrifuged and the beads were 
washed in lysis buffer. Equal volumes of protein precipitant 
were subjected to 10% SDS-PAGE and transferred to a 
PVDF membrane followed by blocking with 5% 
BSA-TTBS. Western blot analysis was performed using 
HSRG1 or Cyclin T2 antisera as primary antibodies and 
sheep anti-mouse IgG-HRP as the secondary antibody for 
DAB reaction. 
1.9  Chloramphenicol acetyltransferase (CAT) activity 
analysis  
CHO cells were transfected and incubated for 48 h at 37°C. 
The CAT and β-galactosidase activities in CHO cell extracts 
in each group were detected by the CAT enzyme assay sys-
tem and the β-gal enzyme assay system, respectively, in ac-
cord with standard protocols (Promega). β-gal activity val-
ues were used to normalize CAT activity values. The rela-
tive CAT activity in each experimental group was calcu-
lated by defining the CAT activity values detected by 
co-transfection of pcDNA3 plasmid and CAT reporter gene 
expression plasmids as 100. The results were presented as 
the mean values obtained from three independent experi-
ments. 
1.10  Analysis of protein localization 
Vero cells incubated for 40 h after co-transfection with 
pRed-HSRG1 and pEGFP-CycT2 plasmids were examined 
with an immunofluorescent microscope. Photographs were 
taken and merged to analyze the locations of fluorescent 
fusion proteins.  
1.11  Statistical analysis 
All data were statistically analyzed according to standard 
protocols. Results are expressed as means±SD. Statistical 
significance was determined using two-way analysis of 
variance and the Student’s t-test using SPSS 11.0 software. 
P-values<0.05 were considered statistically significant. 
2  Results 
2.1  Expression of HSRG1 delays the proliferation of 
HSV-1  
HSRG1 is a host protein expressed during HSV-1 infection. 
To analyze the effect of HSRG1 on HSV-1 proliferation, 
Western blot analysis was performed on extracts from 
transfected Vero cells using HSRG1 antisera as the primary 
antibody. The results showed that HSRG1 was expressed in 
pcDNA3-HSRG1-transfected cells (Figure 1A). Plaque as-
says were then used to analyze the effects of HSRG1 on 
virus titer. Vero cells transfected with pcDNA3-HSRG1 or 
pcDNA3 were infected with HSV-1 at an MOI of 0.5, 24 h 
after transfection. Viruses were harvested at 12 or 24 h. The 
results showed that virus titers in cells transfected with 
pcDNA3-HSRG1 were lower than in the control group, 
indicating that high expression of HSRG1 delayed the pro-
liferation of HSV-1 (Figure 1B). 
2.2  HSRG1 inhibits transcriptional elongation effi-
ciency on HSV-1 α4, TK, and gC promoters  
To analyze the effect of HSRG1 on virus proliferation, CAT 
assays were carried out to detect the transcriptional regula-
tory effect of HSRG1 on HSV-1 gene promoters. The eu- 
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Figure 1  Expression of HSRG1 protein in Vero cells and its effect on 
HSV-1 proliferation. A, Vero cells transfected with pcDNA3 or pcDNA3- 
HSRG1 were harvested 24 h after transfection, and the expression of 
HSRG1 was detected by Western blotting using anti-HSRG1 antiserum. 
Tubulin was detected by anti-Tubulin antiserum as a loading control. B, 
Vero cells were transfected with pcDNA3-HSRG1 or pcDNA3, incubated 
at 37°C for 24 h, and infected with HSV-1 at MOI 0.5. Virus was harvested  
at 36 h. Virus titers were tested by a virus plaque assay. * indicates P<0.05. 
karyotic expression plasmid pcDNA3-HSRG1 was co-       
transfected with reporter plasmids pCAT-α4, pCAT-TK, or 
pCAT-gC into CHO-K1 cells. CAT activity was measured 
to analyze the effects of HSRG1 on different viral gene 
promoters. The results showed that HSRG1 protein had dif-
ferent inhibitory effects on HSV-1 immediate-early, early, 
and late gene transcription (Figure 2) and that this effect 
was somewhat dose-dependent.  
2.3  HSRG1 interacts with Cyclin T2a protein 
To analyze proteins interacting with HSRG1, we selected a 
number of possible candidate proteins using yeast two-      
hybrid experiments. A human liver cell cDNA library was 
screened using HSRG1 as the bait protein (Table 2). Cyclin 
T2 was one of the candidate proteins. Cyclin T2 contains 
several conserved structural domains, including an 
N-terminal Cyclin box, a histidine rich region, and a leucine 
rich region. These are important for the formation of the 
P-TEFb complex by Cyclin T2/CDK9 dimerization and for 
binding with RNAP II. In this study, recombinant plasmids 
pGBKT7-CycT2a, pGBKT7-T2a-250A, pGBKT7-T2a-300A, 
and pGBKT7-T2a-420A were constructed by ligating the 
sequences of Cyclin T2 and a series of truncated fragments 
of its N-terminal 250, 300, and 420 amino acids (Figure 3A) 
into the pGBKT7 vector. AH109 yeast cells transfected  
 
Figure 2  Dose-response curve for transcriptional repression of HSRG1 
on HSV-1 promoters. 1 mg of CAT reporter plasmid CAT-α4, CAT-TK, 
or CAT-gC was co-transfected into Vero cells with different amounts of 
pcDNA3-HSRG1. The amount of total transfected DNA was kept constant 
by addition of pcDNA3 in every well. Cells were harvested at 48 h. The 
relative CAT activity values in each experimental group were calculated by 
assigning a value of 100 to CAT activity values detected by transfecting  
1 μg CAT reporter gene expression plasmids and 1 μg pcDNA3. 
Table 2  Candidate genes encoding proteins interacting with HSRG1  
No. Gene Accession No. 
11 cyclinT2 NM-00124 
43 flotillin1 BC-001146 
70 SR-A1 NM-021228 
112 unknown protein AW-307598 
145 SV40 large T antigen NP-043127 
 
with these recombinant plasmids were fused with Y187 
yeast cells transfected with pGADT7-HSRG1. The results 
suggested that potential interactions existed between 
HSRG1 and multiple regions of Cyclin T2 (Figure 3B). 
β-galactosidase activity of yeast clones grown on SD/-Ade- 
His-Leu-Trp plates was detected, suggesting that amino 
acids 1–250 and 300–420 of Cyclin T2a have significant 
contributions to protein interactions (Figure 3D). 
Yeast two-hybrid experiments showed that the physical 
interaction of HSRG1 and Cyclin T2 is mediated by amino 
acids 1–250 and 300–420 of Cyclin T2. The former contains 
the cyclin box, a conserved domain that could bind to 
CDK9. To further verify the relationship between these two 
proteins in cells, immunoprecipitation was performed using 
anti-HSRG1 antiserum in Vero cells transfected with 
pcDNA3-HSRG1 and pcDNA3-CycT2a. Cyclin T2 com-
plexed with HSRG1 was detected by co-immunoprecipita-        
tion, followed by Western blotting with anti-Cyclin T2 an-
tiserum (Figure 3C). These results confirmed the interaction 
between HSRG1 and Cyclin T2. Additionally, a yeast 
two-hybrid β-gal assay also revealed the amino acid regions 
responsible for the interaction between HSRG1 and Cyclin 
T2 (Figure 3D). 
2.4  HSRG1 protein colocalizes with Cyclin T2 protein 
in living cells  
To verify the interaction between HSRG1 and Cyclin T2 in  




Figure 3  Protein interactions between HSRG1 and Cyclin T2a. A, Schematic for Cyclin T2a and a series of truncated fragments. A series of recombination 
plasmids was constructed by separately inserting the sequence of Cyclin T2 cDNA, or sequences encoding amino acids 1–250, 1–300, and 1–420 of Cycling 
T2, into the pGBKT7 vector. These plasmids were used in yeast two-hybrid assays. B, Table of Scores for yeast growth on SD/-Leu-Trp (DDO), 
SD/-His-Leu-Trp (TDO), and SD/-Ade-His-Leu-Trp (QDO) plates. Y187 yeast cells transformed with pGADT7-HSRG1 were fused with AH109 yeast cells 
transformed with pGBKT7-CycT2a or pGBKT7-T2a-250A/300A/420A. Plate mating culture and controls on appropriate SD selection media are shown. 
Plates were incubated at 30°C until colonies appeared and subsequently scored for growth. C, Immunoprecipitation of HSRG1 and Cyclin T2a. Vero cells 
grown in 10-cm dishes to 80% confluence were transfected with pcDNA3-HSRG1 and pcDNA3-CycT2a. Immunoprecipitation was performed in Vero cells 
40 h after transfection using HSRG1 antiserum. Western blots were carried out using HSRG1 or Cyclin T2a antisera. Mock, lytic supernatants from untrans-
fected Vero cells; Input, Part of the transfected cells lytic supernatant was reserved as an input sample. D, β-galactosidase activity. Clones were isolated and 
inoculated in SD/-Leu-Trp liquid medium. Yeast cells were collected when the A600 value reached 0.5–0.8. Lysate supernatants of yeast cells were incubated 
with ONPG and the reaction was terminated when the solution turned yellow. Reaction time and A420 values were recorded. β-D-galactosidase activity units 
were calculated by the following formula: β-D-galactosidase units=1000×A420/t×5×A600 (where A600 is equal to the A600 absorption value of 1 mL culture and t  
is the reaction time). The results are presented as mean values obtained from three independent experiments. 
living cells, recombinant plasmids pRed-HSRG1 and 
pEGFP-T2a were constructed and transfected into Vero 
cells. HSRG1 was expressed as a fusion protein with red 
fluorescent protein, and Cyclin T2a was expressed as a fu-
sion protein with green fluorescent protein. The distribution 
of fluorescent proteins was observed at 48 h. As shown in 
Figure 4, Cyclin T2a-GFP localized in the nucleus and 
HSRG1-RFP localized in the cytoplasm when plasmids 
pRed-HSRG1 or pEGFP-T2a were transfected alone (Figure 
4A). However, colocalization of both signals was observed 
in both the nucleus and the cytoplasm when the two plas-
mids were co-transfected into Vero cells (Figure 4B). Taken 
together, these experiments suggested that the HSRG1 pro-
tein interacts with Cyclin T2 protein in cells, and that the 
cellular localizations of these two proteins were changed to 
some extent by these interactions. 
2.5  HSRG1 can block the promotion of Cyclin T2-me-     
diated transcriptional activation of HSV-1 virus pro-
moters  
Our experiments indicated that HSRG1 could interact with  
Cyclin T2. Furthermore, CAT assays showed inhibitory 
effects of HSRG1 on several viral gene promoters. Consid-
ering the biological significance of Cyclin T2 in the P-TEFb 
transcriptional elongation factor complex, CAT reporter 
gene activity was assessed in CHO-K1 cells co-transfected 
with pcDNA3-HSRG1 or pcDNA3-CycT2a together with 
CAT reporter plasmids to analyze the effect of HSRG1 on 
transcriptional promotion by Cyclin T2. The results re-
vealed that transcriptional activation of immediate-early, 
early, and late HSV-1 promoters was upregulated in cells 
transfected with pcDNA3-CycT2a, whereas, in cells 
co-transfected with pcDNA3-HSRG1 and pcDNA3-CycT2a, 
the presence of HSRG1 was able to block Cyclin T2-me-       
diated transcriptional activation of different viral promoters 
(Figure 5A–C). Thus, HSRG1, a protein expressed in the 
early stages of HSV-1 infection, binds with Cyclin T2, the 
regulatory subunit of the P-TEFb transcriptional elongation 
complex to downregulate Cyclin T2-mediated activation of 
viral promoters during HSV-1 infection. It is likely that 
HSRG1 functions to inhibit viral proliferation by inhibiting 
activation of viral promoters.  
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Figure 4  Fluorescent colocalization of Cyclin T2a and HSRG1. A, Cellular localization of Cyclin T2a or HSRG1. Green fluorescence indicates the cellular 
location of a Cyclin T2a fusion protein expressed by pEGFP-CycT2a (abbreviated as GFP-T2a), and red fluorescence indicates the location of a HSRG1 
fusion protein expressed by pDsRed-HSRG1 (abbreviated as Red-HSRG1). B, Cyclin T2a colocalizes with HSRG1. a–d, Vero cells transfected with pEGFP  
and pDsRed plasmids. e–h, Vero cells transfected with pEGFP-CycT2a and pDsRed-HSRG1 plasmids. 
3  Discussion 
Proteins induced by viral infection have been intensively 
studied [6,7,10] and the functions of these proteins have 
been gradually clarified. HSRG1, belonging to the con-
served SAND protein family, is one of the proteins upregu-
lated in early stages of HSV-1 infection. As a member of 
the SAND family, it is important to understand the func-
tions of HSRG1. We previously found that HSRG1 specifi-
cally interacts with amino acids 132–450 of the SV40 large 
T antigen, and that transcriptional activity of SV40 promot-
ers activated by large T was inhibited by HSRG1 [10]. We 
suggested that HSRG1 might have a role in cellular tran-
scriptional regulation. The results presented here indicate 
that upregulation of HSRG1 inhibits proliferation of HSV-1. 
In addition, CAT assays found that HSRG1 inhibits tran-
scriptional elongation efficiency on the HSV-1 α4, TK, and 
gC promoters and that this effect was somewhat dose-      
dependent. These results suggested that HSRG1 has an im-
portant role in viral gene transcription.  
Transcription in eukaryotic cells involves three major steps: 
initiation, elongation, and termination. After successful initia-
tion of RNA synthesis, RNA pol II can pause, be arrested, 
pass through terminator sequences, or terminate transcrip-
tion. The post-initiation processivity of RNA pol II is con-
trolled by both negative and positive factors. The P-TEFb 
complex is composed of a catalytic subunit (cy-
clin-dependent kinase CDK9) and a subunit, Cyclin T2. 
Cyclin T2 is proposed to facilitate the transition from abor-
tive to productive elongation by phosphorylating the 
C-terminal domain (CTD) of the largest subunit of RNA pol 
II [12]. Cyclin T2 has two forms, termed T2a and T2b, 
which likely arise by alternative splicing of the primary 
transcript. Although they share the N-terminus, they have 
different carboxy termini [14], both of which can bind with 
CDK9 to form a P-TEFb complex to promote transcrip-
tional efficiency by productive transcriptional elongation. 
Like all Cyclin T proteins, Cyclin T2a contains two con-
served domains: the Cyclin box, formed by 250 amino acids 
that can bind with CDK9, and the histidine-rich stretch, 
which binds to the CTD of RNAP II and direct the tran-
scriptional activity of the P-TEFb complex. In addition to 
these two domains, Kurosu et al. [15] found a leucine-rich 
region next to the cyclin boxes in Cyclin T2, which are re-
sponsible for maintaining appreciable transcriptional activ-
ity and binding RNAP II via its CTD. It has been suggested 
that Cyclin T2a exerts its positive effect by interacting with 
CDK9 and RNAP II via different domains to shorten their 
spatial distance, promoting the phosphorylation of the larg-
est subunit CTD of RNA pol II by CDK9. In this study, a  
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Figure 5  HSRG1 inhibits Cyclin T2-mediated transcriptional activation 
of HSV-1 virus promoters. A–C, HSRG1 inhibits Cyclin T2-mediated 
activation of α4, TK, or gC promoters. 1 mg of reporter plasmid CAT-α4 
(Figure 5A), CAT-TK (Figure 5B), or CAT-gC (Figure 5C) was 
co-transfected into CHO cells with different combinations of 1 μg 
pcDNA3-HSRG1 or 1 μg pcDNA3-CycT2a. The total amount of trans-
fected DNA was kept constant by the addition of pcDNA3 in every well. 
Samples were harvested 48 h after transfection. The relative CAT activity 
in each experimental group was calculated by defining the CAT activity 
values detected by the combination of pcDNA3 plasmid and CAT reporter  
gene expression plasmid transfection as 100, n=3. * indicates P<0.05. 
yeast two-hybrid analysis showed that multiple regions of 
Cyclin T2a are important for interaction with HSRG1, in-
cluding the N-terminal Cyclin box domain. Fluorescent 
protein localization experiments analyzed the effect of this 
interaction on the spatial location of these proteins. These 
results established that HSRG1 and Cyclin T2a localized in 
the cytoplasm and nucleus separately when plasmids were 
transfected alone, while the nuclear localization of Cyclin 
T2 was partly blocked by HSRG1. Furthermore, some 
HSRG1 was transferred to the nucleus by Cyclin T2 when 
the plasmids were co-transfected. Therefore, it is reasonable 
to speculate that the biological function of Cyclin T2a might 
be affected by binding with HSRG1. The effect of HSRG1 
on transcriptional promotion by Cyclin T2a was analyzed. 
The results demonstrated that HSRG1 could reverse the 
positive transcriptional regulation of Cyclin T2 and could 
inhibit the expression of multiple HSV-1 genes, to varying 
degrees. This inhibitory effect could be explained by 
HSRG1 blocking or depleting Cyclin T2 such that tran-
scriptional efficiency was downregulated because of re-
duced levels of P-TEFb complexes. Considering the asso-
ciation of HSV-1 infection and high expression of HSRG1, 
it is likely that HSRG1 constitutes a cellular defense against 
viruses by limiting viral gene duplication in infected cells.  
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